RedHill Biopharma to conduct ondansetron bioequivalence trial
The study protocol was reviewed and cleared by the FDA and Health Canada. RedHill has submitted an IND to the FDA and Clinical Trial Application (CTA) to Health
Isomorphic Labs has raised $5bn in a Series C financing round to support the development of its AI platform and advance its therapeutic candidates towards clinical evaluation.
Meridian Medical Technologies, a Pfizer subsidiary, has signed a settlement agreement with Intelliject and Sanofi that will resolve pending patent litigation related to Intelliject’s NDA for its epinephrine